Lv3
310 积分 2022-10-11 加入
Efficacy and Safety of Indobufen in Patients with Coronary Artery Disease: A Systematic Review and Meta-Analysis
1天前
待确认
Three-month dual antiplatelet therapy after percutaneous coronary intervention: time for a new standard
1天前
已完结
Ticagrelor alone versus ticagrelor plus aspirin from month 1 to month 12 after percutaneous coronary intervention in patients with acute coronary syndromes (ULTIMATE-DAPT): a randomised, placebo-controlled, double-blind clinical trial
1天前
已完结
Management of Antithrombotic Therapy after Acute Coronary Syndromes
13天前
已完结
Safety and Efficacy of Aspirin and Indobufen in the Treatment of Atherosclerotic Diseases: Systematic Review and Meta-Analysis
20天前
已完结
Indobufen versus aspirin in patients with indication for antiplatelet therapy: A systematic review and meta-analysis
21天前
已完结
Extended Clopidogrel Monotherapy vs DAPT in Patients With Acute Coronary Syndromes at High Ischemic and Bleeding Risk
1个月前
已完结
P2Y12inhibitor or aspirin after percutaneous coronary intervention: individual patient data meta-analysis of randomised clinical trials
1个月前
已完结
Abelacimab Versus Rivaroxaban in Patients With Atrial Fibrillation on Antiplatelet Therapy: A Prespecified Analysis of the AZALEA-TIMI 71 Trial
2个月前
已完结
Effect of acid and pepsin on blood coagulation and platelet aggregation
2个月前
已完结
皖公网安备34019202002308
